Menu

Press Releases

Date Summary View
Toggle Summary Egalet and RedHill Biopharma enter into License Agreement
Egalet and RedHill Biopharma enter into an exclusive license agreement to develop, and commercialize Egalet’s EG-P042 (Carvedilol) for the treatment of certain cardiac diseases ...
View HTML
Toggle Summary SCOLR Pharma and RedHill Biopharma enter into Licensing Agreement
SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd. ...
View HTML
Toggle Summary IntelGenx and RedHill Announce Definitive Agreement
IntelGenx and RedHill Announce Definitive Agreement for Anti-Migraine Film Product ...
View HTML
Toggle Summary Giaconda Completes Sale of 3 Products to RedHill Biopharma
Sale of patents brings significant cash injection into Giaconda<br> Giaconda stands to benefit if the patents are successfully commercialised ...
View HTML
Toggle Summary RedHill Biopharma Raises $3.5M in a Private Placement
The Company Reports the Closing of Two Transactions and the Possibility of an IPO ...
View HTML
Toggle Summary IntelGenx Exhibits VersaFilm Triptan (RHB-103) Poster at CPhl Paris View HTML
Toggle Summary (Hebrew) RedHill Announces Successful Completion of $10m Financing - 3 Times More than Originally Planned View HTML
Toggle Summary RedHill Announces Successful Completion of $10m Financing - 3 Times More than Originally Planned View HTML
Toggle Summary RedHill Biopharma Announces Successful IPO on the Tel Aviv Stock Exchange View HTML
Toggle Summary (Hebrew) Tel Aviv Stock Exchange Ticker and ISIN Details: Share and Warrant View HTML